Kenza Health Hub logoGet Started
1 May 2026Oral drugsSource update: February 2024

Metoclopramide Oral: Dosing and Precautions

Metoclopramide guidance for symptomatic nausea and vomiting in adults, with strict duration and neurological safety limits.

Also searched as

Metoclopramide
Prescription under medical supervision

Source reviewed

February 2024

Guide category

Oral drugs

Safety boundary

Prescription medicine information for clinician-guided use.

Kenza Health Hub presents this medicine page as structured health education. Check dose, route, interactions, pregnancy or breast-feeding considerations, and local protocol with a qualified clinician or pharmacist. Read our medical editorial policy.

This guide page is for structured reference only and does not replace a clinician, pharmacist, or emergency review. Dose choice, route choice, interactions, and safety decisions still need professional judgment.

Therapeutic action

Antiemetic (dopamine antagonist).

Indications

Symptomatic treatment of nausea and vomiting in adults.

Forms and strengths

  • 10 mg tablet.

Dose

The interval between each dose should be at least 6 hours, even in the event of vomiting.

  • Adult under 60 kg: 5 mg 3 times daily.
  • Adult over 60 kg: 10 mg 3 times daily.

Duration

Maximum 5 days.

Contra-indications, adverse effects, precautions

  • Do not administer to children under 18 years or to patients with gastrointestinal haemorrhage, obstruction, or perforation.
  • Reduce the dose by half in patients with severe renal impairment.
  • Administer with caution and monitor use in patients over 60 years and patients with epilepsy or Parkinson's disease.
  • May cause drowsiness, dizziness, confusion, extrapyramidal symptoms, seizures, allergic reactions, and rarely neuroleptic malignant syndrome requiring immediate discontinuation.
  • Do not combine with levodopa because of antagonism.
  • Avoid combination with CNS depressants.
  • Avoid alcohol during treatment.
  • Pregnancy: no contra-indication.
  • Breast-feeding: no contra-indication.

Source

MSF Essential drugs practical guidelines (January 2026)

This page combines source-derived medicine reference sections with Kenza editorial context, while leaving out the Storage and Remarks sections from the source batch.

Rate this guide

Be the first to rate this guide.